nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA5A—glaucoma	0.22	0.651	CbGaD
Celecoxib—CA2—glaucoma	0.09	0.266	CbGaD
Celecoxib—PTGS2—glaucoma	0.0282	0.0834	CbGaD
Celecoxib—CA14—Diclofenamide—glaucoma	0.0167	0.0336	CbGbCtD
Celecoxib—CA14—Brinzolamide—glaucoma	0.0167	0.0336	CbGbCtD
Celecoxib—CA14—Dorzolamide—glaucoma	0.0161	0.0325	CbGbCtD
Celecoxib—CA5A—Diclofenamide—glaucoma	0.0158	0.0319	CbGbCtD
Celecoxib—CA6—Brinzolamide—glaucoma	0.0158	0.0319	CbGbCtD
Celecoxib—CA6—Diclofenamide—glaucoma	0.0158	0.0319	CbGbCtD
Celecoxib—CA5A—Brinzolamide—glaucoma	0.0158	0.0319	CbGbCtD
Celecoxib—CA6—Dorzolamide—glaucoma	0.0153	0.0308	CbGbCtD
Celecoxib—CA5A—Dorzolamide—glaucoma	0.0153	0.0308	CbGbCtD
Celecoxib—CA14—Methazolamide—glaucoma	0.0143	0.0289	CbGbCtD
Celecoxib—CA5B—Diclofenamide—glaucoma	0.0138	0.0278	CbGbCtD
Celecoxib—CA5B—Brinzolamide—glaucoma	0.0138	0.0278	CbGbCtD
Celecoxib—CA6—Methazolamide—glaucoma	0.0136	0.0275	CbGbCtD
Celecoxib—CA5A—Methazolamide—glaucoma	0.0136	0.0275	CbGbCtD
Celecoxib—CA5B—Dorzolamide—glaucoma	0.0133	0.0269	CbGbCtD
Celecoxib—CA5B—Methazolamide—glaucoma	0.0119	0.024	CbGbCtD
Celecoxib—CA12—Brinzolamide—glaucoma	0.0118	0.0239	CbGbCtD
Celecoxib—CA9—Diclofenamide—glaucoma	0.0118	0.0239	CbGbCtD
Celecoxib—CA12—Diclofenamide—glaucoma	0.0118	0.0239	CbGbCtD
Celecoxib—CA9—Brinzolamide—glaucoma	0.0118	0.0239	CbGbCtD
Celecoxib—CA14—Acetazolamide—glaucoma	0.0115	0.0231	CbGbCtD
Celecoxib—CA9—Dorzolamide—glaucoma	0.0114	0.0231	CbGbCtD
Celecoxib—CA12—Dorzolamide—glaucoma	0.0114	0.0231	CbGbCtD
Celecoxib—CA6—Acetazolamide—glaucoma	0.0109	0.022	CbGbCtD
Celecoxib—CA5A—Acetazolamide—glaucoma	0.0109	0.022	CbGbCtD
Celecoxib—CA4—Brinzolamide—glaucoma	0.0104	0.021	CbGbCtD
Celecoxib—CA4—Diclofenamide—glaucoma	0.0104	0.021	CbGbCtD
Celecoxib—CA9—Methazolamide—glaucoma	0.0102	0.0206	CbGbCtD
Celecoxib—CA12—Methazolamide—glaucoma	0.0102	0.0206	CbGbCtD
Celecoxib—CA4—Dorzolamide—glaucoma	0.0101	0.0203	CbGbCtD
Celecoxib—CA2—Brinzolamide—glaucoma	0.00957	0.0193	CbGbCtD
Celecoxib—CA2—Diclofenamide—glaucoma	0.00957	0.0193	CbGbCtD
Celecoxib—CA5B—Acetazolamide—glaucoma	0.0095	0.0192	CbGbCtD
Celecoxib—CA2—Dorzolamide—glaucoma	0.00925	0.0187	CbGbCtD
Celecoxib—CA4—Methazolamide—glaucoma	0.00897	0.0181	CbGbCtD
Celecoxib—CA2—Methazolamide—glaucoma	0.00824	0.0166	CbGbCtD
Celecoxib—CA12—Acetazolamide—glaucoma	0.00815	0.0164	CbGbCtD
Celecoxib—CA9—Acetazolamide—glaucoma	0.00815	0.0164	CbGbCtD
Celecoxib—CA4—Acetazolamide—glaucoma	0.00717	0.0145	CbGbCtD
Celecoxib—CA2—Acetazolamide—glaucoma	0.00659	0.0133	CbGbCtD
Celecoxib—CYP2D6—Carteolol—glaucoma	0.0026	0.00525	CbGbCtD
Celecoxib—CYP2D6—Betaxolol—glaucoma	0.00176	0.00354	CbGbCtD
Celecoxib—CYP2C9—Diclofenamide—glaucoma	0.00169	0.00341	CbGbCtD
Celecoxib—CYP2C9—Dorzolamide—glaucoma	0.00163	0.00329	CbGbCtD
Celecoxib—CYP2C9—Methazolamide—glaucoma	0.00146	0.00294	CbGbCtD
Celecoxib—CYP2D6—Methazolamide—glaucoma	0.00133	0.00269	CbGbCtD
Celecoxib—CYP3A4—Pilocarpine—glaucoma	0.00125	0.00253	CbGbCtD
Celecoxib—CYP2D6—Timolol—glaucoma	0.00113	0.00228	CbGbCtD
Celecoxib—CYP3A4—Brinzolamide—glaucoma	0.000983	0.00198	CbGbCtD
Celecoxib—CYP2D6—Clonidine—glaucoma	0.000962	0.00194	CbGbCtD
Celecoxib—CYP3A4—Dorzolamide—glaucoma	0.00095	0.00192	CbGbCtD
Celecoxib—CYP3A4—Methazolamide—glaucoma	0.000846	0.00171	CbGbCtD
Celecoxib—CYP3A4—Acetazolamide—glaucoma	0.000677	0.00136	CbGbCtD
Celecoxib—CYP3A4—Clonidine—glaucoma	0.000612	0.00123	CbGbCtD
Celecoxib—Etoricoxib—PTGS2—glaucoma	0.000309	1	CrCbGaD
Celecoxib—Dyspnoea—Pilocarpine—glaucoma	4.53e-05	0.000485	CcSEcCtD
Celecoxib—Somnolence—Pilocarpine—glaucoma	4.52e-05	0.000484	CcSEcCtD
Celecoxib—Angiopathy—Betaxolol—glaucoma	4.51e-05	0.000483	CcSEcCtD
Celecoxib—Pruritus—Bimatoprost—glaucoma	4.5e-05	0.000482	CcSEcCtD
Celecoxib—Immune system disorder—Betaxolol—glaucoma	4.49e-05	0.000481	CcSEcCtD
Celecoxib—Diarrhoea—Apraclonidine—glaucoma	4.49e-05	0.000481	CcSEcCtD
Celecoxib—Mediastinal disorder—Betaxolol—glaucoma	4.48e-05	0.00048	CcSEcCtD
Celecoxib—Dyspepsia—Pilocarpine—glaucoma	4.47e-05	0.000479	CcSEcCtD
Celecoxib—Syncope—Clonidine—glaucoma	4.46e-05	0.000478	CcSEcCtD
Celecoxib—Arrhythmia—Betaxolol—glaucoma	4.44e-05	0.000476	CcSEcCtD
Celecoxib—Feeling abnormal—Dorzolamide—glaucoma	4.43e-05	0.000475	CcSEcCtD
Celecoxib—Decreased appetite—Pilocarpine—glaucoma	4.42e-05	0.000473	CcSEcCtD
Celecoxib—Feeling abnormal—Travoprost—glaucoma	4.41e-05	0.000473	CcSEcCtD
Celecoxib—Conjunctivitis—Timolol—glaucoma	4.4e-05	0.000471	CcSEcCtD
Celecoxib—Gastrointestinal pain—Dorzolamide—glaucoma	4.4e-05	0.000471	CcSEcCtD
Celecoxib—Alopecia—Betaxolol—glaucoma	4.39e-05	0.000471	CcSEcCtD
Celecoxib—Palpitations—Clonidine—glaucoma	4.39e-05	0.000471	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Pilocarpine—glaucoma	4.39e-05	0.00047	CcSEcCtD
Celecoxib—Gastrointestinal pain—Travoprost—glaucoma	4.38e-05	0.000469	CcSEcCtD
Celecoxib—Loss of consciousness—Clonidine—glaucoma	4.37e-05	0.000468	CcSEcCtD
Celecoxib—Feeling abnormal—Brinzolamide—glaucoma	4.36e-05	0.000467	CcSEcCtD
Celecoxib—Mental disorder—Betaxolol—glaucoma	4.36e-05	0.000467	CcSEcCtD
Celecoxib—Constipation—Pilocarpine—glaucoma	4.35e-05	0.000466	CcSEcCtD
Celecoxib—Cough—Clonidine—glaucoma	4.34e-05	0.000465	CcSEcCtD
Celecoxib—Dizziness—Apraclonidine—glaucoma	4.34e-05	0.000465	CcSEcCtD
Celecoxib—Urticaria—Dorzolamide—glaucoma	4.27e-05	0.000458	CcSEcCtD
Celecoxib—Epistaxis—Timolol—glaucoma	4.27e-05	0.000457	CcSEcCtD
Celecoxib—Abdominal pain—Dorzolamide—glaucoma	4.25e-05	0.000455	CcSEcCtD
Celecoxib—Body temperature increased—Dorzolamide—glaucoma	4.25e-05	0.000455	CcSEcCtD
Celecoxib—Tension—Betaxolol—glaucoma	4.25e-05	0.000455	CcSEcCtD
Celecoxib—Sinusitis—Timolol—glaucoma	4.25e-05	0.000455	CcSEcCtD
Celecoxib—Dysgeusia—Betaxolol—glaucoma	4.24e-05	0.000454	CcSEcCtD
Celecoxib—Arthralgia—Clonidine—glaucoma	4.23e-05	0.000454	CcSEcCtD
Celecoxib—Chest pain—Clonidine—glaucoma	4.23e-05	0.000454	CcSEcCtD
Celecoxib—Abdominal pain—Travoprost—glaucoma	4.23e-05	0.000454	CcSEcCtD
Celecoxib—Agranulocytosis—Timolol—glaucoma	4.22e-05	0.000452	CcSEcCtD
Celecoxib—Anxiety—Clonidine—glaucoma	4.22e-05	0.000452	CcSEcCtD
Celecoxib—Asthenia—Acetazolamide—glaucoma	4.21e-05	0.000451	CcSEcCtD
Celecoxib—Dizziness—Bimatoprost—glaucoma	4.21e-05	0.000451	CcSEcCtD
Celecoxib—Nervousness—Betaxolol—glaucoma	4.2e-05	0.00045	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	4.2e-05	0.00045	CcSEcCtD
Celecoxib—Urticaria—Brinzolamide—glaucoma	4.2e-05	0.00045	CcSEcCtD
Celecoxib—Feeling abnormal—Pilocarpine—glaucoma	4.19e-05	0.000449	CcSEcCtD
Celecoxib—Vomiting—Apraclonidine—glaucoma	4.17e-05	0.000447	CcSEcCtD
Celecoxib—Muscle spasms—Betaxolol—glaucoma	4.16e-05	0.000446	CcSEcCtD
Celecoxib—Gastrointestinal pain—Pilocarpine—glaucoma	4.16e-05	0.000445	CcSEcCtD
Celecoxib—Hypersensitivity—Brimonidine—glaucoma	4.15e-05	0.000445	CcSEcCtD
Celecoxib—Dry mouth—Clonidine—glaucoma	4.14e-05	0.000444	CcSEcCtD
Celecoxib—Dermatitis—Apraclonidine—glaucoma	4.13e-05	0.000443	CcSEcCtD
Celecoxib—Headache—Apraclonidine—glaucoma	4.11e-05	0.00044	CcSEcCtD
Celecoxib—Confusional state—Clonidine—glaucoma	4.09e-05	0.000438	CcSEcCtD
Celecoxib—Vision blurred—Betaxolol—glaucoma	4.08e-05	0.000437	CcSEcCtD
Celecoxib—Rhinitis—Timolol—glaucoma	4.07e-05	0.000436	CcSEcCtD
Celecoxib—Oedema—Clonidine—glaucoma	4.06e-05	0.000435	CcSEcCtD
Celecoxib—Hallucination—Timolol—glaucoma	4.04e-05	0.000433	CcSEcCtD
Celecoxib—Asthenia—Brimonidine—glaucoma	4.04e-05	0.000433	CcSEcCtD
Celecoxib—Infection—Clonidine—glaucoma	4.03e-05	0.000432	CcSEcCtD
Celecoxib—Abdominal pain—Pilocarpine—glaucoma	4.02e-05	0.00043	CcSEcCtD
Celecoxib—Body temperature increased—Pilocarpine—glaucoma	4.02e-05	0.00043	CcSEcCtD
Celecoxib—Diarrhoea—Acetazolamide—glaucoma	4.01e-05	0.00043	CcSEcCtD
Celecoxib—Rash—Bimatoprost—glaucoma	4.01e-05	0.00043	CcSEcCtD
Celecoxib—Dermatitis—Bimatoprost—glaucoma	4.01e-05	0.000429	CcSEcCtD
Celecoxib—Oedema peripheral—Timolol—glaucoma	4e-05	0.000429	CcSEcCtD
Celecoxib—Anaemia—Betaxolol—glaucoma	4e-05	0.000429	CcSEcCtD
Celecoxib—Shock—Clonidine—glaucoma	3.99e-05	0.000428	CcSEcCtD
Celecoxib—Connective tissue disorder—Timolol—glaucoma	3.99e-05	0.000428	CcSEcCtD
Celecoxib—Pruritus—Brimonidine—glaucoma	3.98e-05	0.000427	CcSEcCtD
Celecoxib—Headache—Bimatoprost—glaucoma	3.98e-05	0.000427	CcSEcCtD
Celecoxib—Nervous system disorder—Clonidine—glaucoma	3.98e-05	0.000426	CcSEcCtD
Celecoxib—Thrombocytopenia—Clonidine—glaucoma	3.97e-05	0.000426	CcSEcCtD
Celecoxib—Hypersensitivity—Dorzolamide—glaucoma	3.96e-05	0.000425	CcSEcCtD
Celecoxib—Tachycardia—Clonidine—glaucoma	3.96e-05	0.000424	CcSEcCtD
Celecoxib—Hypersensitivity—Travoprost—glaucoma	3.95e-05	0.000423	CcSEcCtD
Celecoxib—Skin disorder—Clonidine—glaucoma	3.94e-05	0.000422	CcSEcCtD
Celecoxib—Hyperhidrosis—Clonidine—glaucoma	3.92e-05	0.00042	CcSEcCtD
Celecoxib—Nausea—Apraclonidine—glaucoma	3.9e-05	0.000417	CcSEcCtD
Celecoxib—Hypersensitivity—Brinzolamide—glaucoma	3.9e-05	0.000417	CcSEcCtD
Celecoxib—Vertigo—Betaxolol—glaucoma	3.89e-05	0.000417	CcSEcCtD
Celecoxib—Syncope—Betaxolol—glaucoma	3.88e-05	0.000416	CcSEcCtD
Celecoxib—Dizziness—Acetazolamide—glaucoma	3.88e-05	0.000416	CcSEcCtD
Celecoxib—Anorexia—Clonidine—glaucoma	3.87e-05	0.000414	CcSEcCtD
Celecoxib—Asthenia—Dorzolamide—glaucoma	3.86e-05	0.000413	CcSEcCtD
Celecoxib—Asthenia—Travoprost—glaucoma	3.84e-05	0.000412	CcSEcCtD
Celecoxib—Palpitations—Betaxolol—glaucoma	3.83e-05	0.00041	CcSEcCtD
Celecoxib—Pruritus—Dorzolamide—glaucoma	3.81e-05	0.000408	CcSEcCtD
Celecoxib—Loss of consciousness—Betaxolol—glaucoma	3.81e-05	0.000408	CcSEcCtD
Celecoxib—Eye disorder—Timolol—glaucoma	3.8e-05	0.000407	CcSEcCtD
Celecoxib—Asthenia—Brinzolamide—glaucoma	3.79e-05	0.000406	CcSEcCtD
Celecoxib—Pruritus—Travoprost—glaucoma	3.79e-05	0.000406	CcSEcCtD
Celecoxib—Tinnitus—Timolol—glaucoma	3.79e-05	0.000406	CcSEcCtD
Celecoxib—Cough—Betaxolol—glaucoma	3.78e-05	0.000405	CcSEcCtD
Celecoxib—Nausea—Bimatoprost—glaucoma	3.78e-05	0.000405	CcSEcCtD
Celecoxib—Cardiac disorder—Timolol—glaucoma	3.77e-05	0.000404	CcSEcCtD
Celecoxib—Hypersensitivity—Pilocarpine—glaucoma	3.74e-05	0.000401	CcSEcCtD
Celecoxib—Pruritus—Brinzolamide—glaucoma	3.74e-05	0.000401	CcSEcCtD
Celecoxib—Vomiting—Acetazolamide—glaucoma	3.73e-05	0.0004	CcSEcCtD
Celecoxib—Dizziness—Brimonidine—glaucoma	3.72e-05	0.000399	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Clonidine—glaucoma	3.7e-05	0.000396	CcSEcCtD
Celecoxib—Angiopathy—Timolol—glaucoma	3.69e-05	0.000395	CcSEcCtD
Celecoxib—Arthralgia—Betaxolol—glaucoma	3.69e-05	0.000395	CcSEcCtD
Celecoxib—Chest pain—Betaxolol—glaucoma	3.69e-05	0.000395	CcSEcCtD
Celecoxib—Myalgia—Betaxolol—glaucoma	3.69e-05	0.000395	CcSEcCtD
Celecoxib—Diarrhoea—Dorzolamide—glaucoma	3.68e-05	0.000394	CcSEcCtD
Celecoxib—Headache—Acetazolamide—glaucoma	3.68e-05	0.000394	CcSEcCtD
Celecoxib—Anxiety—Betaxolol—glaucoma	3.67e-05	0.000394	CcSEcCtD
Celecoxib—Insomnia—Clonidine—glaucoma	3.67e-05	0.000393	CcSEcCtD
Celecoxib—Immune system disorder—Timolol—glaucoma	3.67e-05	0.000393	CcSEcCtD
Celecoxib—Diarrhoea—Travoprost—glaucoma	3.66e-05	0.000393	CcSEcCtD
Celecoxib—Mediastinal disorder—Timolol—glaucoma	3.66e-05	0.000392	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	3.66e-05	0.000392	CcSEcCtD
Celecoxib—Asthenia—Pilocarpine—glaucoma	3.65e-05	0.000391	CcSEcCtD
Celecoxib—Paraesthesia—Clonidine—glaucoma	3.64e-05	0.00039	CcSEcCtD
Celecoxib—Arrhythmia—Timolol—glaucoma	3.63e-05	0.000389	CcSEcCtD
Celecoxib—Dyspnoea—Clonidine—glaucoma	3.62e-05	0.000388	CcSEcCtD
Celecoxib—Diarrhoea—Brinzolamide—glaucoma	3.62e-05	0.000388	CcSEcCtD
Celecoxib—Somnolence—Clonidine—glaucoma	3.61e-05	0.000387	CcSEcCtD
Celecoxib—Dry mouth—Betaxolol—glaucoma	3.6e-05	0.000386	CcSEcCtD
Celecoxib—Pruritus—Pilocarpine—glaucoma	3.6e-05	0.000385	CcSEcCtD
Celecoxib—Alopecia—Timolol—glaucoma	3.59e-05	0.000385	CcSEcCtD
Celecoxib—Confusional state—Betaxolol—glaucoma	3.56e-05	0.000382	CcSEcCtD
Celecoxib—Mental disorder—Timolol—glaucoma	3.56e-05	0.000381	CcSEcCtD
Celecoxib—Dizziness—Dorzolamide—glaucoma	3.56e-05	0.000381	CcSEcCtD
Celecoxib—Rash—Brimonidine—glaucoma	3.55e-05	0.00038	CcSEcCtD
Celecoxib—Dermatitis—Brimonidine—glaucoma	3.55e-05	0.00038	CcSEcCtD
Celecoxib—Dizziness—Travoprost—glaucoma	3.54e-05	0.000379	CcSEcCtD
Celecoxib—Oedema—Betaxolol—glaucoma	3.53e-05	0.000379	CcSEcCtD
Celecoxib—Headache—Brimonidine—glaucoma	3.53e-05	0.000378	CcSEcCtD
Celecoxib—Decreased appetite—Clonidine—glaucoma	3.53e-05	0.000378	CcSEcCtD
Celecoxib—Infection—Betaxolol—glaucoma	3.51e-05	0.000376	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Clonidine—glaucoma	3.5e-05	0.000375	CcSEcCtD
Celecoxib—Fatigue—Clonidine—glaucoma	3.5e-05	0.000375	CcSEcCtD
Celecoxib—Dizziness—Brinzolamide—glaucoma	3.5e-05	0.000375	CcSEcCtD
Celecoxib—Nausea—Acetazolamide—glaucoma	3.49e-05	0.000373	CcSEcCtD
Celecoxib—Diarrhoea—Pilocarpine—glaucoma	3.48e-05	0.000373	CcSEcCtD
Celecoxib—Shock—Betaxolol—glaucoma	3.48e-05	0.000372	CcSEcCtD
Celecoxib—Tension—Timolol—glaucoma	3.47e-05	0.000372	CcSEcCtD
Celecoxib—Constipation—Clonidine—glaucoma	3.47e-05	0.000372	CcSEcCtD
Celecoxib—Nervous system disorder—Betaxolol—glaucoma	3.46e-05	0.000371	CcSEcCtD
Celecoxib—Dysgeusia—Timolol—glaucoma	3.46e-05	0.000371	CcSEcCtD
Celecoxib—Thrombocytopenia—Betaxolol—glaucoma	3.46e-05	0.000371	CcSEcCtD
Celecoxib—Tachycardia—Betaxolol—glaucoma	3.45e-05	0.000369	CcSEcCtD
Celecoxib—Nervousness—Timolol—glaucoma	3.43e-05	0.000368	CcSEcCtD
Celecoxib—Skin disorder—Betaxolol—glaucoma	3.43e-05	0.000368	CcSEcCtD
Celecoxib—Vomiting—Dorzolamide—glaucoma	3.42e-05	0.000366	CcSEcCtD
Celecoxib—Hyperhidrosis—Betaxolol—glaucoma	3.42e-05	0.000366	CcSEcCtD
Celecoxib—Rash—Dorzolamide—glaucoma	3.39e-05	0.000363	CcSEcCtD
Celecoxib—Dermatitis—Dorzolamide—glaucoma	3.39e-05	0.000363	CcSEcCtD
Celecoxib—Rash—Travoprost—glaucoma	3.38e-05	0.000362	CcSEcCtD
Celecoxib—Dermatitis—Travoprost—glaucoma	3.37e-05	0.000361	CcSEcCtD
Celecoxib—Headache—Dorzolamide—glaucoma	3.37e-05	0.000361	CcSEcCtD
Celecoxib—Anorexia—Betaxolol—glaucoma	3.37e-05	0.000361	CcSEcCtD
Celecoxib—Vomiting—Brinzolamide—glaucoma	3.36e-05	0.00036	CcSEcCtD
Celecoxib—Dizziness—Pilocarpine—glaucoma	3.36e-05	0.00036	CcSEcCtD
Celecoxib—Headache—Travoprost—glaucoma	3.35e-05	0.000359	CcSEcCtD
Celecoxib—Nausea—Brimonidine—glaucoma	3.35e-05	0.000358	CcSEcCtD
Celecoxib—Feeling abnormal—Clonidine—glaucoma	3.34e-05	0.000358	CcSEcCtD
Celecoxib—Rash—Brinzolamide—glaucoma	3.33e-05	0.000357	CcSEcCtD
Celecoxib—Vision blurred—Timolol—glaucoma	3.33e-05	0.000357	CcSEcCtD
Celecoxib—Dermatitis—Brinzolamide—glaucoma	3.33e-05	0.000357	CcSEcCtD
Celecoxib—Gastrointestinal pain—Clonidine—glaucoma	3.32e-05	0.000356	CcSEcCtD
Celecoxib—Headache—Brinzolamide—glaucoma	3.31e-05	0.000355	CcSEcCtD
Celecoxib—Angioedema—Timolol—glaucoma	3.23e-05	0.000346	CcSEcCtD
Celecoxib—Vomiting—Pilocarpine—glaucoma	3.23e-05	0.000346	CcSEcCtD
Celecoxib—Urticaria—Clonidine—glaucoma	3.22e-05	0.000345	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Betaxolol—glaucoma	3.22e-05	0.000345	CcSEcCtD
Celecoxib—Abdominal pain—Clonidine—glaucoma	3.21e-05	0.000344	CcSEcCtD
Celecoxib—Body temperature increased—Clonidine—glaucoma	3.21e-05	0.000344	CcSEcCtD
Celecoxib—Rash—Pilocarpine—glaucoma	3.2e-05	0.000343	CcSEcCtD
Celecoxib—Dermatitis—Pilocarpine—glaucoma	3.2e-05	0.000343	CcSEcCtD
Celecoxib—Insomnia—Betaxolol—glaucoma	3.2e-05	0.000342	CcSEcCtD
Celecoxib—Nausea—Dorzolamide—glaucoma	3.19e-05	0.000342	CcSEcCtD
Celecoxib—Headache—Pilocarpine—glaucoma	3.18e-05	0.000341	CcSEcCtD
Celecoxib—Nausea—Travoprost—glaucoma	3.18e-05	0.000341	CcSEcCtD
Celecoxib—Vertigo—Timolol—glaucoma	3.18e-05	0.00034	CcSEcCtD
Celecoxib—Paraesthesia—Betaxolol—glaucoma	3.17e-05	0.00034	CcSEcCtD
Celecoxib—Syncope—Timolol—glaucoma	3.17e-05	0.00034	CcSEcCtD
Celecoxib—Dyspnoea—Betaxolol—glaucoma	3.15e-05	0.000337	CcSEcCtD
Celecoxib—Nausea—Brinzolamide—glaucoma	3.14e-05	0.000336	CcSEcCtD
Celecoxib—Palpitations—Timolol—glaucoma	3.13e-05	0.000335	CcSEcCtD
Celecoxib—Dyspepsia—Betaxolol—glaucoma	3.11e-05	0.000333	CcSEcCtD
Celecoxib—Loss of consciousness—Timolol—glaucoma	3.11e-05	0.000333	CcSEcCtD
Celecoxib—Cough—Timolol—glaucoma	3.09e-05	0.000331	CcSEcCtD
Celecoxib—Decreased appetite—Betaxolol—glaucoma	3.07e-05	0.000329	CcSEcCtD
Celecoxib—Hypertension—Timolol—glaucoma	3.05e-05	0.000327	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Betaxolol—glaucoma	3.05e-05	0.000327	CcSEcCtD
Celecoxib—Fatigue—Betaxolol—glaucoma	3.05e-05	0.000326	CcSEcCtD
Celecoxib—Constipation—Betaxolol—glaucoma	3.02e-05	0.000324	CcSEcCtD
Celecoxib—Nausea—Pilocarpine—glaucoma	3.02e-05	0.000323	CcSEcCtD
Celecoxib—Arthralgia—Timolol—glaucoma	3.01e-05	0.000323	CcSEcCtD
Celecoxib—Myalgia—Timolol—glaucoma	3.01e-05	0.000323	CcSEcCtD
Celecoxib—Chest pain—Timolol—glaucoma	3.01e-05	0.000323	CcSEcCtD
Celecoxib—Anxiety—Timolol—glaucoma	3e-05	0.000321	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	2.99e-05	0.00032	CcSEcCtD
Celecoxib—Hypersensitivity—Clonidine—glaucoma	2.99e-05	0.00032	CcSEcCtD
Celecoxib—Dry mouth—Timolol—glaucoma	2.94e-05	0.000315	CcSEcCtD
Celecoxib—Asthenia—Clonidine—glaucoma	2.91e-05	0.000312	CcSEcCtD
Celecoxib—Feeling abnormal—Betaxolol—glaucoma	2.91e-05	0.000312	CcSEcCtD
Celecoxib—Confusional state—Timolol—glaucoma	2.91e-05	0.000312	CcSEcCtD
Celecoxib—Anaphylactic shock—Timolol—glaucoma	2.89e-05	0.000309	CcSEcCtD
Celecoxib—Oedema—Timolol—glaucoma	2.89e-05	0.000309	CcSEcCtD
Celecoxib—Pruritus—Clonidine—glaucoma	2.87e-05	0.000308	CcSEcCtD
Celecoxib—Infection—Timolol—glaucoma	2.87e-05	0.000307	CcSEcCtD
Celecoxib—Shock—Timolol—glaucoma	2.84e-05	0.000304	CcSEcCtD
Celecoxib—Nervous system disorder—Timolol—glaucoma	2.83e-05	0.000303	CcSEcCtD
Celecoxib—Urticaria—Betaxolol—glaucoma	2.81e-05	0.000301	CcSEcCtD
Celecoxib—Skin disorder—Timolol—glaucoma	2.8e-05	0.0003	CcSEcCtD
Celecoxib—Body temperature increased—Betaxolol—glaucoma	2.79e-05	0.000299	CcSEcCtD
Celecoxib—Hyperhidrosis—Timolol—glaucoma	2.79e-05	0.000299	CcSEcCtD
Celecoxib—Diarrhoea—Clonidine—glaucoma	2.78e-05	0.000297	CcSEcCtD
Celecoxib—Anorexia—Timolol—glaucoma	2.75e-05	0.000295	CcSEcCtD
Celecoxib—Dizziness—Clonidine—glaucoma	2.68e-05	0.000288	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Timolol—glaucoma	2.63e-05	0.000282	CcSEcCtD
Celecoxib—Insomnia—Timolol—glaucoma	2.61e-05	0.00028	CcSEcCtD
Celecoxib—Hypersensitivity—Betaxolol—glaucoma	2.6e-05	0.000279	CcSEcCtD
Celecoxib—Paraesthesia—Timolol—glaucoma	2.59e-05	0.000278	CcSEcCtD
Celecoxib—Vomiting—Clonidine—glaucoma	2.58e-05	0.000276	CcSEcCtD
Celecoxib—Dyspnoea—Timolol—glaucoma	2.57e-05	0.000276	CcSEcCtD
Celecoxib—Somnolence—Timolol—glaucoma	2.57e-05	0.000275	CcSEcCtD
Celecoxib—Rash—Clonidine—glaucoma	2.56e-05	0.000274	CcSEcCtD
Celecoxib—Dermatitis—Clonidine—glaucoma	2.56e-05	0.000274	CcSEcCtD
Celecoxib—Headache—Clonidine—glaucoma	2.54e-05	0.000272	CcSEcCtD
Celecoxib—Dyspepsia—Timolol—glaucoma	2.54e-05	0.000272	CcSEcCtD
Celecoxib—Asthenia—Betaxolol—glaucoma	2.53e-05	0.000272	CcSEcCtD
Celecoxib—Decreased appetite—Timolol—glaucoma	2.51e-05	0.000269	CcSEcCtD
Celecoxib—Pruritus—Betaxolol—glaucoma	2.5e-05	0.000268	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Timolol—glaucoma	2.49e-05	0.000267	CcSEcCtD
Celecoxib—Fatigue—Timolol—glaucoma	2.49e-05	0.000267	CcSEcCtD
Celecoxib—Diarrhoea—Betaxolol—glaucoma	2.42e-05	0.000259	CcSEcCtD
Celecoxib—Nausea—Clonidine—glaucoma	2.41e-05	0.000258	CcSEcCtD
Celecoxib—Feeling abnormal—Timolol—glaucoma	2.38e-05	0.000255	CcSEcCtD
Celecoxib—Gastrointestinal pain—Timolol—glaucoma	2.36e-05	0.000253	CcSEcCtD
Celecoxib—Dizziness—Betaxolol—glaucoma	2.34e-05	0.00025	CcSEcCtD
Celecoxib—Urticaria—Timolol—glaucoma	2.29e-05	0.000246	CcSEcCtD
Celecoxib—Body temperature increased—Timolol—glaucoma	2.28e-05	0.000244	CcSEcCtD
Celecoxib—Abdominal pain—Timolol—glaucoma	2.28e-05	0.000244	CcSEcCtD
Celecoxib—Vomiting—Betaxolol—glaucoma	2.25e-05	0.000241	CcSEcCtD
Celecoxib—Rash—Betaxolol—glaucoma	2.23e-05	0.000239	CcSEcCtD
Celecoxib—Dermatitis—Betaxolol—glaucoma	2.23e-05	0.000238	CcSEcCtD
Celecoxib—Headache—Betaxolol—glaucoma	2.21e-05	0.000237	CcSEcCtD
Celecoxib—Hypersensitivity—Timolol—glaucoma	2.13e-05	0.000228	CcSEcCtD
Celecoxib—Nausea—Betaxolol—glaucoma	2.1e-05	0.000225	CcSEcCtD
Celecoxib—Asthenia—Timolol—glaucoma	2.07e-05	0.000222	CcSEcCtD
Celecoxib—Pruritus—Timolol—glaucoma	2.04e-05	0.000219	CcSEcCtD
Celecoxib—Diarrhoea—Timolol—glaucoma	1.97e-05	0.000212	CcSEcCtD
Celecoxib—Dizziness—Timolol—glaucoma	1.91e-05	0.000204	CcSEcCtD
Celecoxib—Vomiting—Timolol—glaucoma	1.84e-05	0.000197	CcSEcCtD
Celecoxib—Rash—Timolol—glaucoma	1.82e-05	0.000195	CcSEcCtD
Celecoxib—Dermatitis—Timolol—glaucoma	1.82e-05	0.000195	CcSEcCtD
Celecoxib—Headache—Timolol—glaucoma	1.81e-05	0.000194	CcSEcCtD
Celecoxib—Nausea—Timolol—glaucoma	1.71e-05	0.000184	CcSEcCtD
Celecoxib—CA5B—Metabolism—MTHFR—glaucoma	8.87e-06	0.000123	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—APOE—glaucoma	8.84e-06	0.000122	CbGpPWpGaD
Celecoxib—CA6—Metabolism—APOE—glaucoma	8.84e-06	0.000122	CbGpPWpGaD
Celecoxib—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	8.82e-06	0.000122	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	8.78e-06	0.000122	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—VEGFA—glaucoma	8.77e-06	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—glaucoma	8.76e-06	0.000121	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CAV1—glaucoma	8.76e-06	0.000121	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CAV1—glaucoma	8.76e-06	0.000121	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CDKN2B—glaucoma	8.75e-06	0.000121	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—C3—glaucoma	8.7e-06	0.00012	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGFR1OP—glaucoma	8.66e-06	0.00012	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HEYL—glaucoma	8.66e-06	0.00012	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—MMP1—glaucoma	8.66e-06	0.00012	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	8.63e-06	0.00012	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	8.52e-06	0.000118	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—glaucoma	8.34e-06	0.000116	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—CAV1—glaucoma	8.3e-06	0.000115	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—APOE—glaucoma	8.25e-06	0.000114	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CDKN1B—glaucoma	8.25e-06	0.000114	CbGpPWpGaD
Celecoxib—CA12—Metabolism—MTHFR—glaucoma	8.21e-06	0.000114	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TNF—glaucoma	8.2e-06	0.000114	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CAV1—glaucoma	8.18e-06	0.000113	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NTRK2—glaucoma	8.16e-06	0.000113	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CDKN1B—glaucoma	8.01e-06	0.000111	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—C3—glaucoma	7.95e-06	0.00011	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CDKN1B—glaucoma	7.92e-06	0.00011	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—FN1—glaucoma	7.9e-06	0.000109	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—glaucoma	7.89e-06	0.000109	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—glaucoma	7.68e-06	0.000106	CbGpPWpGaD
Celecoxib—CA12—Metabolism—APOE—glaucoma	7.65e-06	0.000106	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—VEGFA—glaucoma	7.62e-06	0.000105	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—BCL2L1—glaucoma	7.61e-06	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—MMP1—glaucoma	7.58e-06	0.000105	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CAV1—glaucoma	7.58e-06	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—CDKN1B—glaucoma	7.51e-06	0.000104	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CYP1B1—glaucoma	7.49e-06	0.000104	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ABCA1—glaucoma	7.49e-06	0.000104	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GSTM1—glaucoma	7.41e-06	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7.4e-06	0.000102	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—CYP1B1—glaucoma	7.38e-06	0.000102	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MTHFR—glaucoma	7.34e-06	0.000102	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	7.27e-06	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—CAV1—glaucoma	7.27e-06	0.000101	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CA1—glaucoma	7.25e-06	0.0001	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—glaucoma	7.23e-06	0.0001	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.2e-06	9.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RPTOR—glaucoma	7.2e-06	9.97e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GSTM1—glaucoma	7.11e-06	9.84e-05	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—glaucoma	7.11e-06	9.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—C3—glaucoma	7.09e-06	9.82e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CTSA—glaucoma	7.03e-06	9.73e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NGFR—glaucoma	7e-06	9.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NCK2—glaucoma	6.97e-06	9.65e-05	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—glaucoma	6.95e-06	9.62e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	6.93e-06	9.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—FN1—glaucoma	6.92e-06	9.58e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—BAD—glaucoma	6.9e-06	9.55e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—APOE—glaucoma	6.83e-06	9.46e-05	CbGpPWpGaD
Celecoxib—CA14—Metabolism—NOS3—glaucoma	6.8e-06	9.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—BCL2L1—glaucoma	6.79e-06	9.4e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB2—glaucoma	6.78e-06	9.39e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CAV1—glaucoma	6.77e-06	9.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—VEGFA—glaucoma	6.66e-06	9.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—glaucoma	6.66e-06	9.22e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NTRK1—glaucoma	6.65e-06	9.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CA2—glaucoma	6.63e-06	9.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.63e-06	9.18e-05	CbGpPWpGaD
Celecoxib—CA6—Metabolism—NOS3—glaucoma	6.62e-06	9.17e-05	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—NOS3—glaucoma	6.62e-06	9.17e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—MTHFR—glaucoma	6.55e-06	9.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.52e-06	9.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NARFL—glaucoma	6.49e-06	8.99e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CA5A—glaucoma	6.49e-06	8.99e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.48e-06	8.98e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.48e-06	8.98e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—BAD—glaucoma	6.37e-06	8.82e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—MTHFR—glaucoma	6.28e-06	8.7e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS3—glaucoma	6.28e-06	8.69e-05	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—glaucoma	6.22e-06	8.61e-05	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—NOS3—glaucoma	6.18e-06	8.57e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—BAD—glaucoma	6.15e-06	8.52e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDKN2B—glaucoma	6.13e-06	8.49e-05	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—glaucoma	6.12e-06	8.48e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—APOE—glaucoma	6.1e-06	8.45e-05	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—glaucoma	6.06e-06	8.39e-05	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—glaucoma	6.06e-06	8.39e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CAV1—glaucoma	6.04e-06	8.37e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GSTM1—glaucoma	5.99e-06	8.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP2—glaucoma	5.98e-06	8.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HDAC9—glaucoma	5.93e-06	8.21e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.9e-06	8.17e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EDN1—glaucoma	5.88e-06	8.15e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CA1—glaucoma	5.87e-06	8.13e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—APOE—glaucoma	5.85e-06	8.1e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.82e-06	8.05e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CAV1—glaucoma	5.79e-06	8.02e-05	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—glaucoma	5.76e-06	7.97e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—NOS3—glaucoma	5.73e-06	7.94e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CTSA—glaucoma	5.68e-06	7.87e-05	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—glaucoma	5.66e-06	7.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.51e-06	7.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS3—glaucoma	5.49e-06	7.61e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NGF—glaucoma	5.41e-06	7.49e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HDAC9—glaucoma	5.41e-06	7.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CA2—glaucoma	5.37e-06	7.43e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MTHFR—glaucoma	5.29e-06	7.33e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.25e-06	7.27e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.25e-06	7.27e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—glaucoma	5.24e-06	7.26e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—C3—glaucoma	5.14e-06	7.12e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SOD1—glaucoma	5.14e-06	7.11e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS3—glaucoma	5.12e-06	7.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—glaucoma	5.03e-06	6.97e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—APOE—glaucoma	4.93e-06	6.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—CDKN2B—glaucoma	4.9e-06	6.79e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CAV1—glaucoma	4.88e-06	6.76e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CA1—glaucoma	4.85e-06	6.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CA1—glaucoma	4.8e-06	6.65e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CDKN1B—glaucoma	4.8e-06	6.65e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—APOE—glaucoma	4.78e-06	6.63e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CAV1—glaucoma	4.74e-06	6.57e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.72e-06	6.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1A—glaucoma	4.7e-06	6.51e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CTSA—glaucoma	4.69e-06	6.5e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—glaucoma	4.68e-06	6.48e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TXN—glaucoma	4.67e-06	6.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CTSA—glaucoma	4.65e-06	6.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SMO—glaucoma	4.64e-06	6.42e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—NOS3—glaucoma	4.57e-06	6.33e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—glaucoma	4.52e-06	6.26e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FN1—glaucoma	4.51e-06	6.25e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—glaucoma	4.49e-06	6.22e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—BAD—glaucoma	4.46e-06	6.17e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CDKN1B—glaucoma	4.43e-06	6.14e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CA2—glaucoma	4.43e-06	6.14e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CA2—glaucoma	4.39e-06	6.09e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—NOS3—glaucoma	4.38e-06	6.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NR3C1—glaucoma	4.3e-06	5.96e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.29e-06	5.95e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.29e-06	5.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CDKN1B—glaucoma	4.28e-06	5.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.27e-06	5.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NTRK2—glaucoma	4.24e-06	5.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.23e-06	5.85e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—glaucoma	4.18e-06	5.79e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.17e-06	5.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—C3—glaucoma	4.13e-06	5.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—glaucoma	4.04e-06	5.59e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—glaucoma	4.01e-06	5.55e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	3.97e-06	5.5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—glaucoma	3.96e-06	5.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BCL2L1—glaucoma	3.95e-06	5.48e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MMP1—glaucoma	3.92e-06	5.43e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TXN—glaucoma	3.78e-06	5.24e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CAV1—glaucoma	3.76e-06	5.2e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NOS3—glaucoma	3.69e-06	5.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGFR—glaucoma	3.64e-06	5.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTT1—glaucoma	3.62e-06	5.02e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—glaucoma	3.58e-06	4.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BAD—glaucoma	3.58e-06	4.96e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—FN1—glaucoma	3.57e-06	4.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—glaucoma	3.46e-06	4.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NTRK1—glaucoma	3.46e-06	4.79e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.45e-06	4.78e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.42e-06	4.74e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—glaucoma	3.42e-06	4.73e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—glaucoma	3.38e-06	4.68e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN2B—glaucoma	3.19e-06	4.41e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CA1—glaucoma	3.17e-06	4.39e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TXN—glaucoma	3.12e-06	4.32e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CDKN1B—glaucoma	3.1e-06	4.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TXN—glaucoma	3.1e-06	4.29e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CTSA—glaucoma	3.07e-06	4.25e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EDN1—glaucoma	3.06e-06	4.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—glaucoma	2.99e-06	4.14e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTT1—glaucoma	2.93e-06	4.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN2B—glaucoma	2.91e-06	4.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CA2—glaucoma	2.9e-06	4.01e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCA1—glaucoma	2.89e-06	4e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP1B1—glaucoma	2.89e-06	4e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—glaucoma	2.88e-06	3.98e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—glaucoma	2.84e-06	3.93e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.82e-06	3.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGF—glaucoma	2.81e-06	3.89e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.8e-06	3.88e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—C3—glaucoma	2.67e-06	3.7e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—glaucoma	2.58e-06	3.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CDKN1B—glaucoma	2.5e-06	3.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—glaucoma	2.49e-06	3.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CAV1—glaucoma	2.46e-06	3.41e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—glaucoma	2.44e-06	3.37e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTT1—glaucoma	2.42e-06	3.35e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTT1—glaucoma	2.4e-06	3.32e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.36e-06	3.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FN1—glaucoma	2.34e-06	3.25e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP1B1—glaucoma	2.34e-06	3.24e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCA1—glaucoma	2.34e-06	3.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—BAD—glaucoma	2.32e-06	3.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—glaucoma	2.31e-06	3.2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—glaucoma	2.27e-06	3.14e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CAV1—glaucoma	2.25e-06	3.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—BAD—glaucoma	2.11e-06	2.93e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—glaucoma	2.05e-06	2.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TXN—glaucoma	2.04e-06	2.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—glaucoma	2.04e-06	2.83e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—glaucoma	1.95e-06	2.7e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.94e-06	2.68e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1B1—glaucoma	1.93e-06	2.67e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCA1—glaucoma	1.93e-06	2.67e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCA1—glaucoma	1.91e-06	2.65e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1B1—glaucoma	1.91e-06	2.65e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—glaucoma	1.9e-06	2.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAV1—glaucoma	1.88e-06	2.61e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—glaucoma	1.87e-06	2.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—glaucoma	1.86e-06	2.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—glaucoma	1.7e-06	2.35e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—glaucoma	1.65e-06	2.29e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CDKN1B—glaucoma	1.61e-06	2.23e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTT1—glaucoma	1.58e-06	2.19e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—glaucoma	1.55e-06	2.14e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—glaucoma	1.54e-06	2.14e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—glaucoma	1.54e-06	2.13e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—glaucoma	1.53e-06	2.12e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAV1—glaucoma	1.52e-06	2.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—glaucoma	1.49e-06	2.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CDKN1B—glaucoma	1.47e-06	2.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—glaucoma	1.42e-06	1.97e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—glaucoma	1.36e-06	1.89e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—glaucoma	1.35e-06	1.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—glaucoma	1.34e-06	1.86e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—glaucoma	1.27e-06	1.76e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCA1—glaucoma	1.26e-06	1.75e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1B1—glaucoma	1.26e-06	1.75e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—glaucoma	1.26e-06	1.74e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAV1—glaucoma	1.26e-06	1.74e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAV1—glaucoma	1.25e-06	1.73e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—glaucoma	1.15e-06	1.59e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—glaucoma	1.05e-06	1.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—glaucoma	1.01e-06	1.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—glaucoma	1.01e-06	1.4e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—glaucoma	9.51e-07	1.32e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—glaucoma	9.42e-07	1.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—glaucoma	8.91e-07	1.23e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—glaucoma	8.69e-07	1.2e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—glaucoma	8.62e-07	1.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—glaucoma	8.3e-07	1.15e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAV1—glaucoma	8.22e-07	1.14e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—glaucoma	6.22e-07	8.61e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—glaucoma	5.68e-07	7.87e-06	CbGpPWpGaD
